Equity Method Investment - Schedule of Balance Sheet Information (Details) - USD ($) |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|---|
| Schedule of Financial Information [Line Items] | |||
| Total current assets | $ 23,811,617 | $ 31,455,631 | |
| Other non-current assets | 33,696 | 54,482 | |
| Total assets | 340,642,232 | 369,852,120 | |
| Total current liabilities | 2,263,762 | 4,018,747 | |
| Total liabilities | 72,704,371 | 117,741,796 | |
| Accumulated deficit | 189,487,263 | 198,527,461 | |
| Total stockholders' equity | 267,937,861 | 252,110,324 | $ (5,900,704) |
| Total liabilities and stockholders' equity | 340,642,232 | 369,852,120 | |
| Variable Interest Entity, Primary Beneficiary [Member] | |||
| Schedule of Financial Information [Line Items] | |||
| Total current assets | 660,788 | 2,330,386 | |
| In process research and development | 613,400,000 | 674,700,000 | |
| Goodwill | 290,025,000 | 534,353,000 | |
| Other non-current assets | 6,559,351 | 5,796,941 | |
| Total assets | 910,645,139 | 1,217,180,327 | |
| Total current liabilities | 3,338,471 | 4,531,668 | |
| Total non-current liabilities | 4,512,028 | 4,238,293 | |
| Total liabilities | 7,850,499 | 8,769,961 | |
| Members' equity | 1,236,803,100 | 1,219,053,100 | |
| Accumulated deficit | (334,008,460) | (10,642,734) | |
| Total liabilities and stockholders' equity | $ 910,645,139 | $ 1,217,180,327 |
| X | ||||||||||
- Definition Inprocess research and development. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of asset recognized for present right to economic benefit. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of asset recognized for present right to economic benefit, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of obligation due after one year or beyond the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of ownership interest in limited liability company (LLC), attributable to the parent entity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of noncurrent assets classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|